By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has granted emergency use authorization for IntelligentMDx's (IMDx) test for the 2009 H1N1 flu virus, the Cambridge, Mass.-based company said today.

The emergency use authorization does not clear the company's Influenza A H1N1 Real-Time RT-PCR Assay for use beyond the period of the 2009 H1N1 influenza public health emergency, which is currently scheduled to expire on April 26, 2010, unless it is renewed or terminated sooner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.